|
|
Staphylococcus aureus Leukocidin A/B (LukAB) Kills Human Monocytes via Host NLRP3 and ASC when Extracellular,but Not Intracellular
|
|
|
|
|
نویسنده
|
melehani j.h. ,james d.b.a. ,dumont a.l. ,torres v.j. ,duncan j.a.
|
منبع
|
plos pathogens - 2015 - دوره : 11 - شماره : 6
|
چکیده
|
Staphylococcus aureus infections are a growing health burden worldwide,and paramount to this bacterium’s pathogenesis is the production of virulence factors,including pore-forming leukotoxins. leukocidin a/b (lukab) is a recently discovered toxin that kills primary human phagocytes,though the underlying mechanism of cell death is not understood. we demonstrate here that lukab is a major contributor to the death of human monocytes. using a variety of in vitro and ex vivo intoxication and infection models,we found that lukab activates caspase 1,promotes il-1β secretion and induces necrosis in human monocytes. using thp1 cells as a model for human monocytes,we found that the inflammasome components nlrp3 and asc are required for lukab-mediated il-1β secretion and necrotic cell death. s. aureus was shown to kill human monocytes in a lukab dependent manner under both extracellular and intracellular ex vivo infection models. although lukab-mediated killing of thp1 monocytes from extracellular s. aureus requires asc,nlrp3 and the lukab-receptor cd11b,lukab-mediated killing from phagocytosed s. aureus is independent of asc or nlrp3,but dependent on cd11b. altogether,this study provides insight into the nature of lukab-mediated killing of human monocytes. the discovery that s. aureus lukab provokes differential host responses in a manner dependent on the cellular contact site is critical for the development of anti-infective/anti-inflammatory therapies that target the nlrp3 inflammasome. © 2015 melehani et al.
|
|
|
آدرس
|
department of pharmacology,university of north carolina at chapel hill,chapel hill,nc, United States, department of microbiology,new york university school of medicine,new york,ny, United States, department of microbiology,new york university school of medicine,new york,ny, United States, department of microbiology,new york university school of medicine,new york,ny, United States, department of pharmacology,university of north carolina at chapel hill,chapel hill,nc,united states,department of medicine,division of infectious diseases,university of north carolina at chapel hill,chapel hill,nc,united states,lineberger comprehensive cancer center,university of north carolina at chapel hill,chapel hill,nc, United States
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|